Molecular Profiling

Decipher Prostate Test Identifies Docetaxel Benefit in Metastatic Prostate Cancer

A UCL-led Cell analysis of STAMPEDE tissue provides randomized-trial evidence that a commercial genomic classifier can guide chemotherapy decisions.